126 related articles for article (PubMed ID: 10725066)
1. Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis.
Ueki Y; Yamasaki S; Kanamoto Y; Kawazu T; Yano M; Matsumoto K; Miyake S; Tominaga Y; Iwamoto U; Suemitsu J; Matsuno Y; Sizume Y; Takenaka Y; Eguchi K
Rheumatology (Oxford); 2000 Feb; 39(2):165-71. PubMed ID: 10725066
[TBL] [Abstract][Full Text] [Related]
2. Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis.
Ueki Y; Nakamura H; Kanamoto Y; Miyazaki M; Yano M; Matsumoto K; Miyake S; Tominaga T; Tominaga M; Yamasaki S; Eguchi K
Ther Apher; 2001 Dec; 5(6):455-61. PubMed ID: 11800080
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis.
Kondoh T; Hidaka Y; Katoh H; Inoue N; Saito S
Artif Organs; 1991 Jun; 15(3):180-8. PubMed ID: 1867528
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis.
Hidaka T; Suzuki K; Kawakami M; Okada M; Kataharada K; Shinohara T; Takamizawa-Matsumoto M; Ohsuzu F
J Clin Apher; 2001; 16(2):74-81. PubMed ID: 11746532
[TBL] [Abstract][Full Text] [Related]
5. Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.
Hidaka T; Suzuki K; Matsuki Y; Takamizawa-Matsumoto M; Kataharada K; Ishizuka T; Kawakami M; Nakamura H
Arthritis Rheum; 1999 Mar; 42(3):431-7. PubMed ID: 10088764
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of filtration leukocytapheresis(LCAP) in rheumatoid arthritis(RA)].
Ueki Y; Takashima H; Matsumoto K; Miyake S; Hidaka T; Suzuki K; Eguchi K
Nihon Rinsho; 2002 Dec; 60(12):2296-303. PubMed ID: 12510353
[TBL] [Abstract][Full Text] [Related]
7. Filtration leukocytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate.
Kempe K; Tsuda H; Yang K; Yamaji K; Kanai Y; Hashimoto H
Ther Apher Dial; 2004 Jun; 8(3):197-205. PubMed ID: 15154871
[TBL] [Abstract][Full Text] [Related]
8. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
Chandrashekara S; Priyanka BU
Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
[TBL] [Abstract][Full Text] [Related]
9. Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis.
Hidaka T; Suzuki K; Matsuki Y; Takamizawa-Matsumoto M; Okada M; Ishizuka T; Kawakami M; Ohsuzu F
Ther Apher; 1999 May; 3(2):178-85. PubMed ID: 10341394
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound evaluation of the effects of leukocytapheresis on rheumatoid arthritis.
Yoshida S; Takeuchi T; Maeda Y; Kimura Y; Hata K; Hiramatsu Y; Shoda T; Makino S; Hanafusa T; Shibahara N
Ther Apher Dial; 2014 Oct; 18(5):509-14. PubMed ID: 24251814
[TBL] [Abstract][Full Text] [Related]
11. Improvement in rheumatoid arthritis following application of an extracorporeal granulotrap column, G-1.
Fujimori J; Yoshino S; Koiwa M; Hirai H; Shiga H; Hayama N; Iino Y
Rheumatol Int; 1996; 15(5):175-80. PubMed ID: 8717100
[TBL] [Abstract][Full Text] [Related]
12. A case report of leukocytapheresis for refractory leg ulcers complicated with rheumatoid arthritis.
Itoh Y; Takeshita Y; Ozawa Y; Tohma S; Umemura S
Ther Apher Dial; 2006 Oct; 10(5):419-24. PubMed ID: 17096696
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: a pilot study.
Nagashima M; Yoshino S; Tanaka H; Yoshida N; Kashiwagi N; Saniabadi AR
Rheumatol Int; 1998; 18(3):113-8. PubMed ID: 9833252
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
[TBL] [Abstract][Full Text] [Related]
15. The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.
Lindqvist UR; Alenius GM; Husmark T; Theander E; Holmström G; Larsson PT;
J Rheumatol; 2008 Apr; 35(4):668-73. PubMed ID: 18278834
[TBL] [Abstract][Full Text] [Related]
16. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
[TBL] [Abstract][Full Text] [Related]
18. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
[TBL] [Abstract][Full Text] [Related]
19. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
Wolfe F
J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-lymphocyte ratio, pain perception, and disease activity score may serve as important predictive markers for sustained remission in rheumatoid arthritis.
Chandrashekara S; Rajendran A; Bai Jaganath A; Krishnamurthy R
Reumatismo; 2015 Dec; 67(3):109-15. PubMed ID: 26876190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
